Veterinary Medicine Information website

Phenocoat 5 mg film-coated tablets for dogs

Authorised
  • Phenobarbital
Download as PDF

Product identification

Medicine name:
Phenocoat 5 mg film-coated tablets for dogs
Active substance:
  • Phenobarbital
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Phenobarbital
    5.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Film-coated tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN03AA02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Sweden
Package description:
  • PVDC/PE/PVC-PVC/Aluminium/Paper blister containing 10 film-coated tablets. Carton box containing 10 film-coated tablets.
  • PVDC/PE/PVC-PVC/Aluminium/Paper blister containing 10 film-coated tablets. Carton box containing 10 tablets.
  • PVDC/PE/PVC-PVC/Aluminium/Paper blister containing 10 film-coated tablets. Carton box containing 30 film-coated tablets.
  • PVDC/PE/PVC-PVC/Aluminium/Paper blister containing 10 film-coated tablets. Carton box containing 40 film-coated tablets.
  • PVDC/PE/PVC-PVC/Aluminium/Paper blister containing 10 film-coated tablets. Carton box containing 50 film-coated tablets.
  • PVDC/PE/PVC-PVC/Aluminium/Paper blister containing 10 film-coated tablets. Carton box containing 60 film-coated tablets.
  • PVDC/PE/PVC-PVC/Aluminium/Paper blister containing 10 film-coated tablets. Carton box containing 70 film-coated tablets.
  • PVDC/PE/PVC-PVC/Aluminium/Paper blister containing 10 film-coated tablets. Carton box containing 80 film-coated tablets.
  • PVDC/PE/PVC-PVC/Aluminium/Paper blister containing 10 film-coated tablets. Carton box containing 100 film-coated tablets.
  • PVDC/PE/PVC-PVC/Aluminium/Paper blister containing 10 film-coated tablets. Carton box containing 250 film-coated tablets.
  • PVDC/PE/PVC-PVC/Aluminium/Paper blister containing 10 film-coated tablets. Carton box containing 90 film-coated tablets.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Bibliographic application (Article 22 of Regulation (EU) 2019/6)
Marketing authorisation holder:
  • Alfasan Nederland B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Alfasan Nederland B.V.
Responsible authority:
  • Swedish Medical Products Agency
Authorisation number:
  • 65351
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0397/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Swedish (PDF)
Published on: 7/10/2025
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Swedish (PDF)
Published on: 7/10/2025
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Swedish (PDF)
Published on: 7/10/2025
Download